Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Initiation
Ecovyst initiated with a Neutral at Citi » 06:42
11/29/21
11/29
06:42
11/29/21
06:42
ECVT

Ecovyst

$9.86 /

-0.04 (-0.40%)

Citi initiated coverage…

Citi initiated coverage of Ecovyst with a Neutral rating and $10.80 price target.

ShowHide Related Items >><<
ECVT Ecovyst
$9.86 /

-0.04 (-0.40%)

ECVT Ecovyst
$9.86 /

-0.04 (-0.40%)

11/16/21 Deutsche Bank
Ecovyst price target lowered to $16 from $20 at Deutsche Bank
08/16/21 BMO Capital
Ecovyst initiated with an Outperform at BMO Capital
ECVT Ecovyst
$9.86 /

-0.04 (-0.40%)

  • 19
    Nov
ECVT Ecovyst
$9.86 /

-0.04 (-0.40%)

ECVT Ecovyst
$9.86 /

-0.04 (-0.40%)

Hot Stocks
Ecovyst falls -13.0% » 12:00
11/19/21
11/19
12:00
11/19/21
12:00
ECVT

Ecovyst

$9.30 /

-1.34 (-12.59%)

Ecovyst is down -13.0%,…

Ecovyst is down -13.0%, or -$1.39 to $9.29.

ShowHide Related Items >><<
ECVT Ecovyst
$9.30 /

-1.34 (-12.59%)

ECVT Ecovyst
$9.30 /

-1.34 (-12.59%)

11/16/21 Deutsche Bank
Ecovyst price target lowered to $16 from $20 at Deutsche Bank
08/16/21 BMO Capital
Ecovyst initiated with an Outperform at BMO Capital
ECVT Ecovyst
$9.30 /

-1.34 (-12.59%)

  • 19
    Nov
ECVT Ecovyst
$9.30 /

-1.34 (-12.59%)

ECVT Ecovyst
$9.30 /

-1.34 (-12.59%)

Hot Stocks
Ecovyst falls -9.6% » 09:47
11/19/21
11/19
09:47
11/19/21
09:47
ECVT

Ecovyst

$9.67 /

-0.97 (-9.12%)

Ecovyst is down -9.6%, or…

Ecovyst is down -9.6%, or -$1.02 to $9.65.

ShowHide Related Items >><<
ECVT Ecovyst
$9.67 /

-0.97 (-9.12%)

ECVT Ecovyst
$9.67 /

-0.97 (-9.12%)

11/16/21 Deutsche Bank
Ecovyst price target lowered to $16 from $20 at Deutsche Bank
08/16/21 BMO Capital
Ecovyst initiated with an Outperform at BMO Capital
ECVT Ecovyst
$9.67 /

-0.97 (-9.12%)

  • 19
    Nov
ECVT Ecovyst
$9.67 /

-0.97 (-9.12%)

ECVT Ecovyst
$9.67 /

-0.97 (-9.12%)

Syndicate
Ecovyst 8M share Secondary priced at $9.50 » 20:16
11/18/21
11/18
20:16
11/18/21
20:16
ECVT

Ecovyst

$10.67 /

-0.055 (-0.51%)

The deal size was cut to…

The deal size was cut to 8M shares from 12.5M shares. Citi, Deutsche Bank and Credit Suisse acted as joint book running managers for the offering.

ShowHide Related Items >><<
ECVT Ecovyst
$10.67 /

-0.055 (-0.51%)

ECVT Ecovyst
$10.67 /

-0.055 (-0.51%)

11/16/21 Deutsche Bank
Ecovyst price target lowered to $16 from $20 at Deutsche Bank
08/16/21 BMO Capital
Ecovyst initiated with an Outperform at BMO Capital
ECVT Ecovyst
$10.67 /

-0.055 (-0.51%)

  • 19
    Nov
ECVT Ecovyst
$10.67 /

-0.055 (-0.51%)

ECVT Ecovyst
$10.67 /

-0.055 (-0.51%)

Hot Stocks
Ecovyst falls -16.1% » 12:01
11/17/21
11/17
12:01
11/17/21
12:01
ECVT

Ecovyst

$10.65 /

-2.055 (-16.17%)

Ecovyst is down -16.1%,…

Ecovyst is down -16.1%, or -$2.05 to $10.67.

ShowHide Related Items >><<
ECVT Ecovyst
$10.65 /

-2.055 (-16.17%)

ECVT Ecovyst
$10.65 /

-2.055 (-16.17%)

11/16/21 Deutsche Bank
Ecovyst price target lowered to $16 from $20 at Deutsche Bank
08/16/21 BMO Capital
Ecovyst initiated with an Outperform at BMO Capital
ECVT Ecovyst
$10.65 /

-2.055 (-16.17%)

  • 19
    Nov
ECVT Ecovyst
$10.65 /

-2.055 (-16.17%)

ECVT Ecovyst
$10.65 /

-2.055 (-16.17%)

Hot Stocks
Ecovyst falls -13.1% » 10:00
11/17/21
11/17
10:00
11/17/21
10:00
ECVT

Ecovyst

$11.06 /

-1.645 (-12.95%)

Ecovyst is down -13.1%,…

Ecovyst is down -13.1%, or -$1.67 to $11.05.

ShowHide Related Items >><<
ECVT Ecovyst
$11.06 /

-1.645 (-12.95%)

ECVT Ecovyst
$11.06 /

-1.645 (-12.95%)

11/16/21 Deutsche Bank
Ecovyst price target lowered to $16 from $20 at Deutsche Bank
08/16/21 BMO Capital
Ecovyst initiated with an Outperform at BMO Capital
ECVT Ecovyst
$11.06 /

-1.645 (-12.95%)

  • 19
    Nov
ECVT Ecovyst
$11.06 /

-1.645 (-12.95%)

ECVT Ecovyst
$11.06 /

-1.645 (-12.95%)

On The Fly
Fly Intel: After-Hours Movers » 18:45
11/16/21
11/16
18:45
11/16/21
18:45
VREX

Varex Imaging

$26.74 /

+1.13 (+4.41%)

, LZB

La-Z-Boy

$37.47 /

+0.44 (+1.19%)

, TTCF

Tattooed Chef

$15.90 /

-0.48 (-2.93%)

, IIIN

Insteel

$43.22 /

+0.125 (+0.29%)

, PAVM

PAVmed

$4.91 /

+0.01 (+0.20%)

, STNE

StoneCo

$31.66 /

+0.3901 (+1.25%)

, DLO

dLocal

$47.03 /

+0.65 (+1.40%)

, DLB

Dolby

$88.89 /

+0.41 (+0.46%)

, LUCD

Lucid Diagnostics

$10.40 /

+0.12 (+1.17%)

, CYTH

Cyclo Therapeutics

$7.31 /

-0.06 (-0.81%)

, AVIR

Atea Pharmaceuticals

$11.35 /

-0.15 (-1.30%)

, RHHBY

Roche

$49.61 /

-0.1003 (-0.20%)

, ECVT

Ecovyst

$12.71 /

-0.115 (-0.90%)

, VRAY

ViewRay

$6.20 /

-0.01 (-0.16%)

, PRVA

Privia Health

$30.95 /

+1.22 (+4.10%)

, EYPT

EyePoint

$14.08 /

-0.2 (-1.40%)

, NKLA

Nikola

$13.35 /

-0.39 (-2.84%)

Check out this evening's…

ShowHide Related Items >><<
VRAY ViewRay
$6.20 /

-0.01 (-0.16%)

TTCF Tattooed Chef
$15.90 /

-0.48 (-2.93%)

STNE StoneCo
$31.66 /

+0.3901 (+1.25%)

RHHBY Roche
$49.61 /

-0.1003 (-0.20%)

PRVA Privia Health
$30.95 /

+1.22 (+4.10%)

PAVM PAVmed
$4.91 /

+0.01 (+0.20%)

NKLA Nikola
$13.35 /

-0.39 (-2.84%)

LZB La-Z-Boy
$37.47 /

+0.44 (+1.19%)

LUCD Lucid Diagnostics
$10.40 /

+0.12 (+1.17%)

IIIN Insteel
$43.22 /

+0.125 (+0.29%)

EYPT EyePoint
$14.08 /

-0.2 (-1.40%)

ECVT Ecovyst
$12.71 /

-0.115 (-0.90%)

DLO dLocal
$47.03 /

+0.65 (+1.40%)

DLB Dolby
$88.89 /

+0.41 (+0.46%)

CYTH Cyclo Therapeutics
$7.31 /

-0.06 (-0.81%)

AVIR Atea Pharmaceuticals
$11.35 /

-0.15 (-1.30%)

VREX Varex Imaging
$26.74 /

+1.13 (+4.41%)

02/05/21 Oppenheimer
Varex Imaging upgraded to Outperform from Perform at Oppenheimer
LZB La-Z-Boy
$37.47 /

+0.44 (+1.19%)

11/19/20 Raymond James
La-Z-Boy price target raised to $46 from $37 at Raymond James
TTCF Tattooed Chef
$15.90 /

-0.48 (-2.93%)

06/11/21
Tattooed Chef management to meet virtually with Roth Capital
12/03/20 Jefferies
Tattooed Chef initiated with a Hold at Jefferies
11/17/20 Roth Capital
Tattooed Chef initiated with a Buy at Roth Capital
IIIN Insteel
$43.22 /

+0.125 (+0.29%)

PAVM PAVmed
$4.91 /

+0.01 (+0.20%)

03/29/21 Cantor Fitzgerald
PAVmed initiated with an Overweight at Cantor Fitzgerald
02/22/21 Lake Street
PAVmed price target raised to $9 from $5 at Lake Street
STNE StoneCo
$31.66 /

+0.3901 (+1.25%)

10/18/21 Susquehanna
StoneCo price target lowered to $65 from $90 at Susquehanna
09/03/21 HSBC
StoneCo price target lowered to $65 from $85 at HSBC
08/31/21 Evercore ISI
StoneCo price target lowered to $84 from $100 at Evercore ISI
08/25/21 BofA
StoneCo press release indicates miss in upcoming Q2, says BofA
DLO dLocal
$47.03 /

+0.65 (+1.40%)

08/19/21 HSBC
dLocal price target raised to $55 from $52 at HSBC
08/06/21 New Street
dLocal initiated with a Neutral at New Street
07/09/21 HSBC
dLocal initiated with a Hold at HSBC
06/28/21
Fly Intel: Top five analyst initiations
DLB Dolby
$88.89 /

+0.41 (+0.46%)

08/02/21
Fly Intel: Top five analyst upgrades
08/02/21 Barrington
Dolby upgraded to Outperform from Market Perform at Barrington
05/26/21 Tigress Financial
Tigress sees Dolby shares hitting $128 over next 12 months
01/29/21 B. Riley
Dolby price target raised to $89 from $79 at B. Riley Securities
LUCD Lucid Diagnostics
$10.40 /

+0.12 (+1.17%)

11/08/21 Canaccord
Lucid Diagnostics initiated with a Buy at Canaccord
11/08/21 Needham
Lucid Diagnostics initiated with a Buy at Needham
11/08/21 BTIG
Lucid Diagnostics initiated with a Buy at BTIG
11/08/21 Cantor Fitzgerald
Lucid Diagnostics initiated with an Overweight at Cantor Fitzgerald
CYTH Cyclo Therapeutics
$7.31 /

-0.06 (-0.81%)

02/10/21 Maxim
Cyclo Therapeutics price target raised to $25 from $12 at Maxim
12/17/20 Maxim
Cyclo Therapeutics initiated with a Buy at Maxim
AVIR Atea Pharmaceuticals
$11.35 /

-0.15 (-1.30%)

10/20/21 SVB Leerink
Atea Pharmaceuticals price target lowered to $20 from $60 at SVB Leerink
10/20/21 JPMorgan
JPMorgan downgrades Atea on 'challenging path forward' in Covid
10/19/21 JPMorgan
Atea Pharmaceuticals downgraded to Neutral from Overweight at JPMorgan
10/19/21 William Blair
William Blair says Atea MOONSONG results raise concerns, but plunge 'premature'
RHHBY Roche
$49.61 /

-0.1003 (-0.20%)

10/21/21 Benchmark
Biogen, Roche calls 'not helpful for Ionis story,' says Benchmark
10/13/21 Morgan Stanley
Roche price target raised to CHF 380 from CHF 370 at Morgan Stanley
09/20/21 Citi
Citi says 'remain upbeat' on Pfizer Covid revenue despite mixed panel vote
ECVT Ecovyst
$12.71 /

-0.115 (-0.90%)

11/16/21 Deutsche Bank
Ecovyst price target lowered to $16 from $20 at Deutsche Bank
08/16/21 BMO Capital
Ecovyst initiated with an Outperform at BMO Capital
VRAY ViewRay
$6.20 /

-0.01 (-0.16%)

11/05/21 Piper Sandler
ViewRay price target raised to $9 from $8 at Piper Sandler
10/19/21 Piper Sandler
ViewRay strength attributed to MIRAGE study recruiting halt, says Piper Sandler
10/14/21 B. Riley
ViewRay resumed with a Neutral at B. Riley
10/14/21 B. Riley
ViewRay resumed with a Neutral at B. Riley
PRVA Privia Health
$30.95 /

+1.22 (+4.10%)

11/09/21 Canaccord
Privia Health price target raised to $50 from $44 at Canaccord
10/13/21 Truist
Privia Health price target lowered to $32 from $40 at Truist
09/27/21 SVB Leerink
SVB Leerink initiates Privia Health with an Outperform, $35 target
09/27/21 SVB Leerink
Privia Health initiated with an Outperform at SVB Leerink
EYPT EyePoint
$14.08 /

-0.2 (-1.40%)

11/16/21 Cantor Fitzgerald
EyePoint stock movement unwarranted, says Cantor Fitzgerald
11/15/21 Cowen
EyePoint price target raised to $35 from $25 at Cowen
11/15/21 Cowen
EyePoint price target raised to $35 from $25 at Cowen
11/15/21 Guggenheim
EyePoint price target raised to $75 from $22 at Guggenheim
NKLA Nikola
$13.35 /

-0.39 (-2.84%)

11/08/21 Wedbush
Nikola price target raised to $15 from $10 at Wedbush
11/05/21 BTIG
Nikola downgraded to Neutral from Buy at BTIG
09/09/21 JPMorgan
Nikola price target lowered to $12 from $21 at JPMorgan
08/11/21
Fly Intel: Top five analyst initiations
VREX Varex Imaging
$26.74 /

+1.13 (+4.41%)

VRAY ViewRay
$6.20 /

-0.01 (-0.16%)

TTCF Tattooed Chef
$15.90 /

-0.48 (-2.93%)

STNE StoneCo
$31.66 /

+0.3901 (+1.25%)

RHHBY Roche
$49.61 /

-0.1003 (-0.20%)

PRVA Privia Health
$30.95 /

+1.22 (+4.10%)

PAVM PAVmed
$4.91 /

+0.01 (+0.20%)

NKLA Nikola
$13.35 /

-0.39 (-2.84%)

LZB La-Z-Boy
$37.47 /

+0.44 (+1.19%)

IIIN Insteel
$43.22 /

+0.125 (+0.29%)

EYPT EyePoint
$14.08 /

-0.2 (-1.40%)

ECVT Ecovyst
$12.71 /

-0.115 (-0.90%)

DLO dLocal
$47.03 /

+0.65 (+1.40%)

DLB Dolby
$88.89 /

+0.41 (+0.46%)

CYTH Cyclo Therapeutics
$7.31 /

-0.06 (-0.81%)

AVIR Atea Pharmaceuticals
$11.35 /

-0.15 (-1.30%)

  • 19
    Nov
  • 19
    Nov
  • 17
    Nov
  • 17
    Nov
  • 17
    Nov
  • 21
    Oct
  • 14
    Oct
  • 03
    Jun
  • 29
    Apr
  • 23
    Feb
  • 02
    Feb
  • 22
    Jan
  • 05
    Jan
STNE StoneCo
$31.66 /

+0.3901 (+1.25%)

RHHBY Roche
$49.61 /

-0.1003 (-0.20%)

NKLA Nikola
$13.35 /

-0.39 (-2.84%)

DLO dLocal
$47.03 /

+0.65 (+1.40%)

DLB Dolby
$88.89 /

+0.41 (+0.46%)

AVIR Atea Pharmaceuticals
$11.35 /

-0.15 (-1.30%)

VREX Varex Imaging
$26.74 /

+1.13 (+4.41%)

TTCF Tattooed Chef
$15.90 /

-0.48 (-2.93%)

STNE StoneCo
$31.66 /

+0.3901 (+1.25%)

RHHBY Roche
$49.61 /

-0.1003 (-0.20%)

PRVA Privia Health
$30.95 /

+1.22 (+4.10%)

PAVM PAVmed
$4.91 /

+0.01 (+0.20%)

NKLA Nikola
$13.35 /

-0.39 (-2.84%)

LZB La-Z-Boy
$37.47 /

+0.44 (+1.19%)

LUCD Lucid Diagnostics
$10.40 /

+0.12 (+1.17%)

EYPT EyePoint
$14.08 /

-0.2 (-1.40%)

DLO dLocal
$47.03 /

+0.65 (+1.40%)

DLB Dolby
$88.89 /

+0.41 (+0.46%)

AVIR Atea Pharmaceuticals
$11.35 /

-0.15 (-1.30%)

VREX Varex Imaging
$26.74 /

+1.13 (+4.41%)

TTCF Tattooed Chef
$15.90 /

-0.48 (-2.93%)

STNE StoneCo
$31.66 /

+0.3901 (+1.25%)

PRVA Privia Health
$30.95 /

+1.22 (+4.10%)

NKLA Nikola
$13.35 /

-0.39 (-2.84%)

LZB La-Z-Boy
$37.47 /

+0.44 (+1.19%)

ECVT Ecovyst
$12.71 /

-0.115 (-0.90%)

DLO dLocal
$47.03 /

+0.65 (+1.40%)

DLB Dolby
$88.89 /

+0.41 (+0.46%)

AVIR Atea Pharmaceuticals
$11.35 /

-0.15 (-1.30%)

Syndicate
Ecovyst announces offering of 12.5M shares of common stock for holders » 16:21
11/16/21
11/16
16:21
11/16/21
16:21
ECVT

Ecovyst

$12.71 /

-0.115 (-0.90%)

Ecovyst announced that…

Ecovyst announced that certain of its stockholders intend to offer for sale 12.5M shares of its common stock pursuant to the company's shelf registration statement filed with the SEC. Citigroup, Deutsche Bank Securities, and Credit Suisse are serving as the joint lead book-running managers of the offering.

ShowHide Related Items >><<
ECVT Ecovyst
$12.71 /

-0.115 (-0.90%)

ECVT Ecovyst
$12.71 /

-0.115 (-0.90%)

11/16/21 Deutsche Bank
Ecovyst price target lowered to $16 from $20 at Deutsche Bank
08/16/21 BMO Capital
Ecovyst initiated with an Outperform at BMO Capital
ECVT Ecovyst
$12.71 /

-0.115 (-0.90%)

ECVT Ecovyst
$12.71 /

-0.115 (-0.90%)

Recommendations
Ecovyst price target lowered to $16 from $20 at Deutsche Bank » 06:51
11/16/21
11/16
06:51
11/16/21
06:51
ECVT

Ecovyst

$12.85 /

-0.115 (-0.89%)

Deutsche Bank analyst…

Deutsche Bank analyst David Begleiter lowered the firm's price target on Ecovyst to $16 from $20 and keeps a Buy rating on the shares. The company had a "solid" Q3 release as EBITDA beat by 11%, implied Q4 guidance bracketed consensus and the company provided a positive, albeit early, outlook for 2022, Begleiter tells investors in a research note.

ShowHide Related Items >><<
ECVT Ecovyst
$12.85 /

-0.115 (-0.89%)

ECVT Ecovyst
$12.85 /

-0.115 (-0.89%)

08/16/21 BMO Capital
Ecovyst initiated with an Outperform at BMO Capital
ECVT Ecovyst
$12.85 /

-0.115 (-0.89%)

ECVT Ecovyst
$12.85 /

-0.115 (-0.89%)

Earnings
Ecovyst raises FY21 revenue view to $590M-$600M from $565M-$575M » 06:19
11/09/21
11/09
06:19
11/09/21
06:19
ECVT

Ecovyst

$12.34 /

+0.1 (+0.82%)

Consensus is for FY21…

Consensus is for FY21 revenue $570.47M. The company increased the outlook based on higher volume and the pass-through of higher sulfur costs. Raises FY21 adjusted EBITDA to $220M-$225M from $215M-$225M based on stronger demand; and adjusted free cash flow to $70M-$80M from $60M-$70M based on improved cash from operations. Given the year to date performance and anticipated continued recovery in underlying demand fundamentals, the Company is upgrading its FY21, guidance noted as below. This outlook reflects the Ecoservices and Catalyst Technologies businesses and excludes Performance Chemicals.

ShowHide Related Items >><<
ECVT Ecovyst
$12.34 /

+0.1 (+0.82%)

ECVT Ecovyst
$12.34 /

+0.1 (+0.82%)

08/16/21 BMO Capital
Ecovyst initiated with an Outperform at BMO Capital
ECVT Ecovyst
$12.34 /

+0.1 (+0.82%)

ECVT Ecovyst
$12.34 /

+0.1 (+0.82%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.